PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New Alzheimer's Association report -- less than half say they were told Alzheimer's diagnosis

Diagnosis disclosure rates for Alzheimer's are significantly lower than other serious diseases

2015-03-24
(Press-News.org) Chicago, March 24, 2015 - The Alzheimer's Association's 2015 Alzheimer's Disease Facts and Figures report, released today, found that only 45 percent of people with Alzheimer's disease or their caregivers say they were told the diagnosis by their doctor. In contrast, more than 90 percent of people with the four most common cancers (breast, colorectal, lung and prostate cancer) say they were told the diagnosis.

"These disturbingly low disclosure rates in Alzheimer's disease are reminiscent of rates seen for cancer in the 1950s and 60s, when even mention of the word cancer was taboo," said Beth Kallmyer, MSW, Vice President of Constituent Services for the Alzheimer's Association. "It is of utmost importance to respect people's autonomy, empower them to make their own decisions and acknowledge that people with Alzheimer's have every right to expect truthful discussions with their physicians. When a diagnosis is disclosed, they can better understand the changes they are experiencing, maximize their quality of life, and often play an active role in planning for the future."

The 2015 Facts and Figures report also found that people with Alzheimer's or their caregivers were more likely to say they were told the diagnosis by their doctor after the disease had become more advanced. According to Kallmyer, this is a problem because learning the diagnosis later in the course of the progressive brain disease may mean the person's capacity to participate in decision making about care plans, or legal and financial issues, may be diminished, and their ability to participate in research or fulfill lifelong plans may be limited.

One of the reasons most commonly cited by health care providers for not disclosing an Alzheimer's diagnosis is fear of causing the patient emotional distress. However, according to the new report, "studies that have explored this issue have found that few patients become depressed or have other long-term emotional problems because of the [Alzheimer's] diagnosis."

Benefits of Disclosing an Alzheimer's Diagnosis According to the Alzheimer's Association, telling the person with Alzheimer's the truth about his or her diagnosis should be standard practice. Disclosure can be delivered in a sensitive and supportive manner that avoids unnecessary distress.

"Based on the principles of medical ethics, there is widespread agreement among health care professionals that people have the right to know and understand their diagnosis, including Alzheimer's disease," said William Klunk, M.D., Ph.D., Chair of the Alzheimer's Association Medical and Scientific Advisory Council. "The findings from this report shine a light on the need for more education for medical students and practicing health care providers on how to effectively make and deliver an Alzheimer's diagnosis."

Dr. Klunk is a Distinguished Professor of Psychiatry and Neurology at the University of Pittsburgh School of Medicine in Pittsburgh, PA, where he also is Co-Director of the Alzheimer's Disease Research Center.

The benefits of promptly and clearly explaining a diagnosis of Alzheimer's have been established in several studies. Benefits include better access to quality medical care and support services, and the opportunity for people with Alzheimer's to participate in decisions about their care, including providing informed consent for current and future treatment plans. Knowing the diagnosis early enables the person with Alzheimer's to get the maximum benefit from available treatments, and may also increase chances of participating in clinical drug trials that help advance research.

The Alzheimer's Epidemic and Its Impact The 2015 Facts and Figures report provides an in-depth look at the prevalence, incidence, mortality and economic impact of Alzheimer's disease and other dementias - all of which continue to rise at staggering rates as the American population ages.

"Alzheimer's is a triple threat unlike any other disease - with soaring prevalence, lack of effective treatment and enormous costs. Promising research is ready for the pipeline, but there's an urgent need to accelerate federal funding to find treatment options that effectively prevent and treat Alzheimer's. Congress must continue its commitment to the fight against Alzheimer's by increasing funding for Alzheimer's research by $300 million in fiscal year 2016, including increased federal research funding for better Alzheimer's diagnostic tools to increase the certainty of diagnosis," Kallmyer said.

Prevalence, Incidence and Mortality: According to the report, an estimated 5.3 million Americans have Alzheimer's disease in 2015. This includes an estimated 5.1 million people age 65 and older, and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer's. Barring the development of medical breakthroughs, the number will rise to 13.8 million by 2050. Almost half a million (approx. 473,000) people age 65 or older will develop Alzheimer's in the U.S. in 2015. Every 67 seconds, someone in the U.S. develops Alzheimer's. By mid-century, an American will develop the disease every 33 seconds. Two-thirds (3.2 million) of Americans over age 65 with Alzheimer's are women. Alzheimer's disease is the sixth-leading cause of death in the U.S., and the fifth-leading cause of death for those age 65 and older. From 2000-2013, the number of Alzheimer's deaths increased 71 percent, while deaths from other major diseases decreased. Heart disease deaths decreased 14 percent; stroke deaths, 23 percent; HIV deaths, 52 percent; prostate cancer deaths, 11 percent; and breast cancer deaths, 2 percent.

Costs and Financial Impact: Alzheimer's is the costliest disease to society. Total 2015 payments for caring for those with Alzheimer's and other dementias are estimated at $226 billion, of which $153 billion is the cost to Medicare and Medicaid alone. Total payments for health care, long-term care and hospice for people with Alzheimer's and other dementias are projected to increase to more than $1 trillion in 2050 (in current dollars). In 2014, the 15.7 million family and other unpaid caregivers of people with Alzheimer's disease and other dementias provided an estimated 17.9 billion hours of unpaid care, a contribution to the nation valued at $217.7 billion (with care valued at $12.17 per hour).

INFORMATION:

Full text of the Alzheimer's Association 2015 Alzheimer's Disease Facts and Figures report can be viewed at http://www.alz.org. The report will also appear in the March 2015 issue of Alzheimer's & Dementia: The Journal of the Alzheimer's Association (volume 11, issue 3), at http://www.alzheimersanddementia.com.

About the Alzheimer's Association 2015 Alzheimer's Disease Facts and Figures Report The Alzheimer's Association 2015 Alzheimer's Disease Facts and Figures report is a comprehensive compilation of national statistics and information on Alzheimer's disease and related dementias. The report conveys the impact of Alzheimer's on individuals, families, government and the nation's health care system. Since its 2007 inaugural release, the report has become the preeminent source covering the broad spectrum of Alzheimer's issues. The Facts and Figures report is an official publication of the Alzheimer's Association.

About the Alzheimer's Association The Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research. It is the largest nonprofit funder of Alzheimer's research. The Association's mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Its vision is a world without Alzheimer's. Visit http://www.alz.org or call 800-272-3900.



ELSE PRESS RELEASES FROM THIS DATE:

Prehistoric super salamander was top predator, fossils suggest

Prehistoric super salamander was top predator, fossils suggest
2015-03-24
A previously undiscovered species of crocodile-like amphibian that lived during the rise of dinosaurs was among Earth's top predators more than 200 million years ago, a study shows. Palaeontologists identified the prehistoric species - which looked like giant salamanders - after excavating bones buried on the site of an ancient lake in southern Portugal. The species was part of a wider group of primitive amphibians that were widespread at low latitudes 220-230 million years ago, the team says. The creatures grew up to 2m in length and lived in lakes and rivers during ...

Mental health report finds staffing problems linked to ward suicides

2015-03-24
Suicidal patients who are under observation may be put at risk by relying on inexperienced staff and agency nurses, according to a new report issued today. Commissioned by the Healthcare Quality Improvement Partnership as part of the Clinical Outcome Review Programmes, researchers from The University of Manchester's National Confidential Inquiry into Suicide and Homicide by People with Mental Illness, found that 18 in-patients a year died by suicide while under observation. This usually meant checks every 10-15 minutes but in 9% the patient was supposed to be under constant ...

India needs to do much more to tackle its alarming TB epidemic

2015-03-24
Effective tuberculosis control in India needs political will and commitment, backed by sufficient resources, says a senior doctor in The BMJ this week. Unless this happens, TB will continue to be India's silent epidemic and a death sentence for poor people, warns consultant physician and public health specialist, Zarir Udwadia. Twenty years ago it was widely believed that India was successfully on its way to controlling its alarming tuberculosis (TB) epidemic. Yet, each year, India has 2.2 million new cases, more than 300,000 deaths, and economic losses of $23bn (£14.9bn; ...

Conscientiousness in childhood is a predictor of adult smoking behavior 

2015-03-24
Conscientious children are less likely to smoke in later life and the personality trait could help explain health inequalities, indicates a study published in the Journal of Epidemiology & Community Health. It is well known that people belonging to lower socio-economic groups have lower life expectancy and more health problems than those who are in higher groups, and certain health behaviours, such as smoking, follow a similar pattern, suggesting they could be partly responsible for health inequalities. Recently, certain personality traits have been found to be associated ...

Several breeds of dog in England killed by mysterious kidney disease 

2015-03-24
At least 30 dogs in England have been killed in less than 18 months by an unknown disease which causes skin lesions and kidney failure, reveals research published in Veterinary Record. The disease is believed to be Alabama rot (cutaneous and renal glomerular vasculopathy), a condition which has been seen in the USA in greyhounds for almost 30 years. While there have been occasional reports of the disease in individual dogs outside of the USA, this is the first report of a series of cases occurring in England. None of the 30 dogs in this English series of cases were greyhounds ...

The Lancet: WHO's new End TB Strategy

2015-03-24
On May 19, 2014, the 67th World Health Assembly (WHA) adopted WHO's "Global strategy and targets for tuberculosis prevention, care and control after 2015". This post-2015 global tuberculosis strategy, labelled the End TB Strategy, was shaped during the past 2 years. A wide range of stakeholders--from ministries of health and national tuberculosis programmes to technical and scientific institutions, financial and development partners, civil society and health activists, non-governmental organisations, and the private sector--contributed to its development. The strategy has ...

Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: A systematic review and meta-analysis

2015-03-24
Microbiological confirmation of childhood tuberculosis is rare because of the difficulty of collection of specimens, low sensitivity of smear microscopy, and poor access to culture. This study, led by Dr Anne Detjen, from the International Union Against Tuberculosis and Lung Disease, aimed to establish summary estimates for sensitivity and specificity of the Xpert MTB/RIF assay compared with microscopy in the diagnosis of pulmonary tuberculosis in children. The researchers found that compared with microscopy, Xpert offers better sensitivity for the diagnosis of pulmonary ...

News from Annals of Internal Medicine March 24, 2015

2015-03-23
1. Task Force finds insufficient evidence to recommend routine screening for thyroid dysfunction The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to recommend for or against screening for thyroid dysfunction in nonpregnant, asymptomatic adults. The recommendations are published in Annals of Internal Medicine. Thyroid gland disorders are among the most common endocrine conditions evaluated and treated by clinicians and may be asymptomatic. If left untreated, thyroid dysfunction could lead to fractures, cancer, or cardiovascular ...

Archeologists discover Maya 'melting pot'

Archeologists discover Maya melting pot
2015-03-23
Archaeologists working in Guatemala have unearthed new information about the Maya civilization's transition from a mobile, hunter-gatherer lifestyle to a sedentary way of life. Led by University of Arizona archaeologists Takeshi Inomata and Daniela Triadan, the team's excavations of the ancient Maya lowlands site of Ceibal suggest that as the society transitioned from a heavy reliance on foraging to farming, mobile communities and settled groups co-existed and may have come together to collaborate on construction projects and participate in public ceremonies. The findings, ...

Supercomputers give universities a competitive edge, researchers find

2015-03-23
CLEMSON, S.C. -- Researchers have long believed that supercomputers give universities a competitive edge in scientific research, but now they have some hard data showing it's true. A Clemson University team found that universities with locally available supercomputers were more efficient in producing research in critical fields than universities that lacked supercomputers. A supercomputer that can do 551 trillion calculations per second is housed at Clemson's Information Technology Center. A supercomputer that can do 551 trillion calculations per second is housed at ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] New Alzheimer's Association report -- less than half say they were told Alzheimer's diagnosis
Diagnosis disclosure rates for Alzheimer's are significantly lower than other serious diseases